Australian Pathology reports that more than 224,000 Australians have accessed Reproductive Carrier Screening

The peak body representing Australia’s private pathology industry, Australian Pathology, reports that the inclusion of Reproductive Carrier Screening to the Medicare Benefits Schedule (MBS) in November 2023 has been a major success. Read the media release here.